Identify the prevalence and pathogenesis of cardiorenal and atherosclerotic cardiovascular complications.
Discuss current guidelines for optimal management of diabetic patients to prevent and treat cardiorenal and atherosclerotic complications.
Examine the causes of inflammation in atherosclerosis.
Target the mechanism of action and indications/contraindications of GLP1-agonists and SGLT2-inhibitors.
Examine the modern therapies for Diabetic Kidney disease.
Recognize the importance of multidisciplinary care in the management of heart disease in patients with diabetes, including collaboration between primary care providers, endocrinologists, cardiologists, and other healthcare professionals.
Identify up to date effective treatment options for managing heart disease in patients with diabetes, including pharmacologic interventions such as beta-blockers, ACE inhibitors, mineralocorticoid antagonists, statins, GLP1-agonists and SGLT2 inhibitors.
Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AccreditationCouncil for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number #4008163.
Physicians (ACCME) Credit Designation Statement Amedco LLC designates this live virtual activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocityfor AANPCP continuing education credit.
Physician Assistants The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for coninuing medical education requirements for recertifications for PAs.
Amedco LLC desginates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.